Signal Genetics (SGNL) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts SGNL Hot Sheet
Join SI Premium – FREE
Signal Genetics (NASDAQ: SGNL) reported Q2 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $734 thousand versus the consensus estimate of $650 thousand.
For earnings history and earnings-related data on Signal Genetics (SGNL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
- Buda Juice, Inc. (BUDA) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
